Here are the DEF 14A proxy statements from Centene Corporation (CNC) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow CNC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CNC filings page.
Centene Corporation is asking stockholders to vote at its 2026 annual meeting on electing nine directors, approving executive pay on an advisory basis, ratifying KPMG as auditor, and a stockholder proposal the Board opposes.
The proxy highlights a challenging 2025, with total revenues of $194.8 billion, a diluted loss per share of $13.53 and adjusted diluted EPS of $2.08, as Medicaid volatility and a sicker Marketplace risk pool pressured results. Management describes corrective actions in pricing, risk management and portfolio focus across Medicaid, Medicare Advantage and Marketplace businesses.
Centene expects 2026 adjusted diluted EPS to exceed $3.00, implying more than 40% year-over-year growth, and points to double-digit improvements in key clinical metrics and strong call-center satisfaction scores. The Board emphasizes governance features such as annual director elections, majority voting, proxy access, a largely independent and refreshed board, and a pay-for-performance compensation design with rigorous stock ownership requirements.